Login

Kathriena Greenwell, M.D. Bariatric Surgery (Weight-loss Surgery) 00:00:00

Share On Facebook Share On Twitter

A fellowship-trained bariatric surgeon and a board certified general surgeon.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Provide sustainable cultivation of cannabis in greenhouses and sustainable production of activated carbon.|David Lesser, CEO,Millennium Investment Acquisition Company Inc
00:10:00
SurgePays, Inc. addresses the needs of |underserved markets in financial technology, telecommunications, and digital media.|Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;
00:10:00
Sailfish Royalty's Portfolio Highlights
00:10:00
CEO Christopher Kingdon Discusses Latest Quarterly Report and Future Growth Prospects | Christopher Kingdon, CEO, Adventure Box Technology AB.
00:10:00
Q3 Results Interview with CEO of Eastnine | Kestutis Sasnauskas, CEO, Eastnine AB.
00:10:00
teaching the intricacies of venture capital|Alex Meyer,Managing Partner,Origin Ventures
00:10:00
American Lithium Corp.: Diverse Assets in Nevada and Peru, Poised for Growth
00:10:00
Shifting Market Dynamics: Evaluating Risk and Opportunity | Sébastien Page, CIO , T. Rowe Price.
00:10:00
Leading AXA: A CEO's Vision for Global Insurance and Societal Impact | Thomas Buberl, CEO , AXA Investment Managers.
00:10:00
Marc Lau Discusses Super Return Conferences and Building Industry Relationships | Marc Lau, Managing Partner,  Axiom Asia.
00:10:00
Resource Industry Outlook: Navigating the Complexities of Today's Market and the ESG Imperative|Evy Hambro,Fund Manager,BlackRock
00:10:00
Join AMC at the Underground Operators Conference in Perth

© 2017 - Neuhu+